We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-9 of 9

A therapy for European patent term extensions: the Neurim case and supplementary protection certificates for "new therapeutic applications"

  • Jones Day
  • -
  • European Union
  • -
  • July 30 2012

On July 19, 2012, the Court of Justice of the European Union ("CJEU") issued its long-awaited decision in case C-13011 Neurim Pharmaceuticals (1991) Ltd v. Comptroller-General of Patents

Europe's highest court decides on patent term extensions for fixed-combination medicinal products

  • Jones Day
  • -
  • European Union, United Kingdom
  • -
  • December 21 2011

Several national patent term extension proceedings regarding fixed-combination medicinal products have been stayed in Europe since UK courts have referred two cases to the highest European courtthe Court of Justice of the European Union

Europe's landmark decision on stem cell patents, or: the strict European view on life

  • Jones Day
  • -
  • European Union
  • -
  • October 31 2011

In a landmark decision on October 18, 2011, the highest court of the European Unionthe Court of Justicedecided on the patentability of stem-cell-related inventions (case number C-3410

Patent term extension for medical devices: new opportunities, open questions

  • Jones Day
  • -
  • Germany
  • -
  • February 15 2011

The first German patent term extension granted for a medical device, a combination product, may open the door for extended patent protection for combination products

No clear pointer in the right direction: validity issues in Europe of patent term extensions covering fixed-combination medicinal products

  • Jones Day
  • -
  • European Union
  • -
  • February 8 2011

Pitfalls loom when applying for patent term extensions covering fixed combination medicinal products

Methods of treatment in Europe: patent claims covering second or further medical uses and dosage regimens

  • Jones Day
  • -
  • European Union
  • -
  • November 18 2010

The decision G 208 of February 19, 2010 (published October 28, 2010) of the Enlarged Board of Appeal (EBA) of the European Patent Office confirms that a substance or composition known as a medicament for treating a certain illness can be patented for use in a different treatment by therapy of the same disease

European Court of Justice restricts scope of biotech patents in Europe: Monsanto loses dispute on soy meal

  • Jones Day
  • -
  • European Union
  • -
  • July 19 2010

The European Court of Justice delivered a judgment on July 6, 2010 that certainly may be seen as a breakthrough decision for European biotechnology patent law

Enlarged Board of Appeal: the EPO's case law on computer-implemented inventions is consistent

  • Jones Day
  • -
  • European Union
  • -
  • May 24 2010

On May 12, 2010, the Enlarged Board of Appeal ("EBA") handed down an Opinion on the patentability of computer-implemented inventions following a referral by the President of the European Patent Office

EU patent term extensions: zeroing in on zero-term SPCs

  • Jones Day
  • -
  • European Union
  • -
  • May 24 2010

The European Court of Justice has been requested to decide on zero-term Supplementary Protection Certificates ("SPC") for patents covering pharmaceutical products for human use

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy